(HealthDay)—Patients with psoriasis have a considerable psychological burden, according to a study published online Dec. 22 in The Journal of Dermatology.
Wiebke Sondermann, M.D., from the University Hospital Essen in Germany, and colleagues examined psychiatric comorbidity and possible correlations between psychological factors, disease severity, and dermatology-related quality of life in psoriatic patients from a university hospital dermatology department. Patients were asked to complete a questionnaire, which included information on demographics, preexisting mental disorders, and data on substance abuse, and explored mental and physical health.
A total of 228 consecutive patients participated in the study between August 2016 and February 2019. The researchers found that about half of the participants had evidence of mental health problems, mostly depression and anxiety and alcohol dependence. A statistically significantly reduced Dermatology Life Quality Index and significantly impaired psychological and physical quality of life were seen for patients with a Psoriasis Area and Severity Index score of 3 or higher.
“Our findings underscore that clinicians should be highly aware of the impact of comorbid mental but also somatic health disorders in psoriatic patients and the central role they play in identifying patients at risk,” the authors write. “Dermatologists should take the opportunity to encourage psoriatic patients to make a change in their lifestyle if necessary by applying patient-centered communication strategies.”
Several authors disclosed financial ties to the pharmaceutical industry.
Inflammation linked to thyroid dysfunction in psoriasis patients
Copyright © 2020 HealthDay. All rights reserved.
Patients with psoriasis shoulder substantial psychological burden (2020, December 28)
retrieved 28 December 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022